Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Payton D Stevens

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Research|September 2, 2021
LGR4: Not Just for Wnt Anymore?Payton D Stevens, Bart O Williams
The Journal of Biological Chemistry|December 24, 2010
mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cellsJianyu Liu, Payton D Stevens, Tianyan Gao
The Journal of Biological Chemistry|July 2, 2013
Protein phosphatase PPM1G regulates protein translation and cell growth by dephosphorylating 4E binding protein 1 (4E-BP1)Jianyu Liu, Payton D Stevens, Nichole E Eshleman, et al.
Molecular and Cellular Biology|October 12, 2011
PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growthJianyu Liu, Payton D Stevens, Xin Li, et al.
Molecular and Cellular Biology|September 25, 2013
Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cellsYang-An Wen, Payton D Stevens, Michael L Gasser, et al.
FEBS Open Bio|September 5, 2022
Mutation of the galectin-3 glycan-binding domain (Lgals3-R200S) enhances cortical bone expansion in male mice and trabecular bone mass in female miceKevin A Maupin, Cassandra R Diegel, Payton D Stevens, et al.
Oncotarget|January 14, 2016
PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cellsAlena J Smith, Yang-An Wen, Payton D Stevens, et al.
The Journal of Biological Chemistry|May 17, 2021
Regulation of Wnt receptor activity: Implications for therapeutic development in colon cancerZhendong A Zhong, Megan N Michalski, Payton D Stevens, et al.
The Journal of Biological Chemistry|June 10, 2010
Tuberous sclerosis complex 2 (TSC2) regulates cell migration and polarity through activation of CDC42 and RAC1Yan Larson, Jianyu Liu, Payton D Stevens, et al.
Gastroenterology|February 18, 2014
PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in miceXin Li, Payton D Stevens, Jianyu Liu, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Research|September 2, 2021
LGR4: Not Just for Wnt Anymore?Payton D Stevens, Bart O Williams
The Journal of Biological Chemistry|December 24, 2010
mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cellsJianyu Liu, Payton D Stevens, Tianyan Gao
The Journal of Biological Chemistry|July 2, 2013
Protein phosphatase PPM1G regulates protein translation and cell growth by dephosphorylating 4E binding protein 1 (4E-BP1)Jianyu Liu, Payton D Stevens, Nichole E Eshleman, et al.
Molecular and Cellular Biology|October 12, 2011
PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growthJianyu Liu, Payton D Stevens, Xin Li, et al.
Molecular and Cellular Biology|September 25, 2013
Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cellsYang-An Wen, Payton D Stevens, Michael L Gasser, et al.
FEBS Open Bio|September 5, 2022
Mutation of the galectin-3 glycan-binding domain (Lgals3-R200S) enhances cortical bone expansion in male mice and trabecular bone mass in female miceKevin A Maupin, Cassandra R Diegel, Payton D Stevens, et al.
Oncotarget|January 14, 2016
PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cellsAlena J Smith, Yang-An Wen, Payton D Stevens, et al.
The Journal of Biological Chemistry|May 17, 2021
Regulation of Wnt receptor activity: Implications for therapeutic development in colon cancerZhendong A Zhong, Megan N Michalski, Payton D Stevens, et al.
The Journal of Biological Chemistry|June 10, 2010
Tuberous sclerosis complex 2 (TSC2) regulates cell migration and polarity through activation of CDC42 and RAC1Yan Larson, Jianyu Liu, Payton D Stevens, et al.
Gastroenterology|February 18, 2014
PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in miceXin Li, Payton D Stevens, Jianyu Liu, et al.
Pageof 2